New Key Statistics Module, Z-Score and F-Score
NAS:OCUL Key Ratios
| Market Cap $ M | 1,581.61 |
| Enterprise Value $ M | 1,229.51 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.48 |
| Price/Sales | 21.54 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 61.00 |
| EPS (TTM) $ | -1.32 |
| Beneish M-Score | -2.56 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -7.70 |
| EV-to-EBITDA | -7.89 |
| PEG | -- |
| Shares Outstanding M | 157.22 |
| Net Margin (%) | -283.75 |
| Operating Margin % | -229.90 |
| Pre-tax Margin (%) | -283.75 |
| Quick Ratio | 12.94 |
| Current Ratio | 13.01 |
| ROA % (ttm) | -44.45 |
| ROE % (ttm) | -70.49 |
| ROIC % (ttm) | -511.29 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.57 |
OCUL Number of Guru Trades
OCUL Volume of Guru Trades
Gurus Latest Trades with NAS:OCUL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:OCUL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ocular Therapeutix Inc Insider Transactions
No Available Data
News about NAS:OCUL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers